NQO2:FAD dimer reduces quinones to hydroquinones - sprookjes - yvandenbroek - TriplyDB

NQO2:FAD dimer reduces quinones to hydroquinones

NQO2:FAD dimer reduces quinones to hydroquinones

http://www.wikidata.org/entity/Q50295344

about

Phase I - Functionalization of compounds

P527

Q45317482-F3CCB6B7-4DFE-400A-BCB6-81C15159AE83

P527

NQO2:FAD dimer reduces quinones to hydroquinones

http://www.wikidata.org/entity/Q50295344

description

An instance of the biological ...... hydroquinones in Homo sapiens

@en

biologisch proces

@nl

name

NQO2:FAD dimer reduces quinones to hydroquinones

@en

type

label

NQO2:FAD dimer reduces quinones to hydroquinones

@en

prefLabel

NQO2:FAD dimer reduces quinones to hydroquinones

@en

P2860

Q50295344-03073F0E-DD2D-44D1-9A1F-F88722411323

Q50295344-35BDF726-E8F8-40C7-9581-05FA45C8C2E8

Q50295344-41A743F0-20DD-4E5A-B223-DED5255E5741

Q50295344-833AABED-06F6-4270-8849-ABD844994F87

Q50295344-88D1CF6A-6AAF-401C-B06E-738CC21707F4

Q50295344-9E0F80D5-87D8-4145-AD62-4B333B60C4D6

Q50295344-A9FDFAAE-B2CA-4918-8FC5-17930DFC5292

Q50295344-C9C70886-E439-49C2-92C1-75D172A5BDD7

Q50295344-EA73533B-61F0-42EF-9932-7BA5C51FB30D

P2888

Q50295344-73335461-6FD5-47E6-AF7D-08E467BE1E09

P31

Q50295344-9DD0B8DB-3F3C-422E-BBF2-0FB9EDF2441C

P361

Q50295344-7CFC9617-AD5D-4F2B-B4FA-B2594539EC82

P3937

Q50295344-A408FD3E-AACE-4E65-8980-7A9D1DAA0900

P527

Q50295344-00EBBECC-9DF1-4FD4-86EA-B6A841D455F4

Q50295344-91C6BBBB-C69E-4536-AD61-B93A9CAB7FC0

Q50295344-E05B2DE1-2C3C-4F09-872E-7B7CE5997354

Q50295344-E9187835-EEB0-450A-8654-83A659B9AEB7

Q50295344-F9099051-E74F-4F1D-AC0E-B0988A1CF1B8

Q50295344-FC37073B-7DC2-47F8-8E35-BBED60EE3500

P703

Q50295344-D2BBFB99-6274-44DA-9F47-C19816D2720A

P2860

Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2

Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase

Crystal structure of quinone reductase 2 in complex with resveratrol

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy

Wine, alcohol, platelets, and the French paradox for coronary heart disease.

Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.

Cardiovascular protective effects of resveratrol.

NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.

P2888

reactome:R-HSA-8936519

P31

biological process

P361

Phase I - Functionalization of compounds

P3937

R-HSA-8936519

http://www.w3.org/2001/XMLSchema#string

P527

1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide

N-ribosylnicotinamide

P703